Clinical Trial Succeeds for Injectable Opioid-Dependence Treatment
A late-stage trial for an injectable treatment for addiction to heroin and other opioids was successful, Braeburn Pharmaceuticals and Camurus AB said. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 14, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Study Suggests Celebrex Isn't Riskier Than Rival Pain Drugs
A major study of drugs used to treat arthritis pain challenges some long-held assumptions about the safety of pills taken by millions of patients world-wide. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 14, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
Study Suggests Celebrex Isn't Riskier Than Rivals
A major study of drugs used to treat arthritis pain challenges some long-held assumptions about the safety of pills taken by millions of patients world-wide. But limitations of the data led some researchers to question the results. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 13, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
Interview: Trump Willing to Keep Parts of Health Law
President-elect Donald Trump, in an exclusive interview, said that after meeting with President Obama he would consider leaving in place certain parts of the Affordable Care Act, an indication of possible compromise after he pledged repeatedly to repeal the health law. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 12, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Affordable Care Act Enrollment Surges Following Trump Election
The government on Thursday reported a surge in people picking plans on the Affordable Care Act ’s federal exchange on the day after voters elected presidential candidate who has pledged to repeal the law. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 11, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Mylan Posts Loss, Hurt by Lower EpiPen Volumes, Charge Related to Settlement
Mylan swung to a quarterly loss as it booked a big charge related to a settlement with authorities on contentious pricing of its EpiPen, and revenue growth came in below expectations as volumes of the lifesaving auto-injector fell. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 9, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
CVS Warns of Prescriptions Shift, Shares Tumble
CVS Health warned that it stands to lose 40 million prescriptions next year as deals signed by rival Walgreens Boots Alliance with other participants in the drug supply chain shut out CVS stores. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 9, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Walgreen Sues Theranos, Seeking to Recover $140 Million
Drugstore giant Walgreen Co. has sued its former lab-testing partner Theranos Inc. in federal court in Delaware, alleging it breached a contract between the two companies. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 9, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Valeant Stock Slides After Profit Forecast Is Chopped
Valeant returned to slashing its annual outlook, signaling the pharmaceutical company is still hemorrhaging from missteps over the past year and indicating it may take longer than expected to remake its business. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 8, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
UPS Acquires Marken to Focus More on Medical Deliveries
United Parcel Service Inc. said Monday it agreed to acquire clinical logistics company Marken Ltd., deepening its push into the profitable business of medical deliveries. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 8, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Demand for Nurses Rises, Pushing Up Wages, Bonuses
After years of relative equilibrium, the job market for nurses is heating up in many markets, driving up wages and sign-on bonuses for the nation ’s fifth-largest occupation. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 8, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
Senate Panel Urges FTC to Review Mylan
Lawmakers continued criticizing Mylan over its EpiPen injector, with two leaders of the Senate Judiciary Committee calling for the Federal Trade Commission to review whether Mylan engaged in anti-competitive practices. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 8, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Worst-Performing Stocks of 2016: Health Care
For health-care stocks, this year ’s worst-performing sector in the S&P 500, any outcome in Tuesday ’s U.S. elections might prove cathartic. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 7, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Japan's Takeda Seeks to Expand Overseas
A potential $10 billion deal to buy Valeant ’s Salix business shows how Japan’s largest drugmaker by sales is betting on the U.S. and Europe for growth. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 3, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Valeant, Pushing to Pare Debt, Weighs Sale of Eye-Surgery Unit
Valeant is exploring a sale of its eye-surgery-equipment business as part of a sweeping effort to unload assets and pare debt. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 3, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
